Drug discovery is slow, expensive, and prone to failure because promising targets and responsive patient groups are difficult to identify early.
R&D Focus
Genomics and multi-omics for patient stratification and treatment selection
Innovative Solution
Inoviv is a startup using a new protein analysis platform to support pharma customers with drug development.
Investment Funding
Last Funding Stage
Venture - Series Unknown
Last Funding Date
30-01-2024
Lead Investors
Foresight Group, Entrepreneurs First, Ada Ventures, Hoxton Ventures
Revenue
$1M to $10M
People
Founders
Ernestas Sirka
Michael Dove
About
Inoviv is a startup using a new protein analysis platform to support pharma customers with drug development. They have a long-term data play in drug discovery and healthcare, addressing huge unmet market needs. Inoviv is backed by Hoxton ventures, early investors in Babylon Health and Deliveroo.
Something missing or incorrect on this page? Help us enrich this information
